Navigation Links
Timothy I. Still Appointed as President and CEO of Myoscience
Date:10/1/2018

Myoscience, Inc. announced today the appointment of Timothy I. Still as its new President and Chief Executive Officer. Mr. Still will also be joining the Company’s Board of Directors.

Mr. Still’s background includes over 28 years of experience in medical devices and diagnostics. He has extensive leadership experience in designing and implementing highly focused commercial and business development strategies within both small and large companies. Mr. Still has been directly responsible for building the commercial viability at many of his previous companies, four of which have been successfully acquired.

Most recently, Mr. Still was the Executive Chairman of Gold Standard Diagnostics. He served on the company’s Board for over four years; and subsequently took on a more active role resulting in the sale of the company to Eurofins in July of 2018. Prior appointments include CEO roles at Global Kinetics Corporation, Xagenic and Accumetrics. Mr. Still has also held executive positions at HemoSense, Cholestech Corporation and Boehringer Mannheim Corporation. He received a B.S. degree (with Honors) in Biological Sciences from the University of California at Davis, and an MBA (Deans Scholar) in Marketing and Entrepreneurship from the University of Southern California.

“I am honored to be given the opportunity to lead Myoscience at this exciting time in the company’s history. With its vast market opportunity, patented technology, increasing commercial adoption and product development pathway, Myoscience is positioned for tremendous success” said Mr. Still.

Brian Farley, Chairman of the Board at Myoscience commented, “We are very pleased to welcome an executive with the leadership and track record of Timothy Still. With his experience in the commercialization of innovative medical technologies, we believe that Tim’s strong operational and business development skills will be instrumental at helping Myoscience successfully execute our strategy of delivering our iovera® pain management solution for the millions of patients with painful conditions, particularly those with osteoarthritis of the knee or who undergo knee replacement surgery.

The board would also like to thank Edward Kleinhans for his leadership during the last five months as Interim Chief Executive Officer at Myoscience.

For additional information, please visit http://www.iovera.com or email us directly at mediarelations@myoscience.com.

ABOUT MYOSCIENCE
Silicon Valley, California-based Myoscience is a privately-held medical device company committed to making its platform technology, the iovera° system, the standard of care for the treatment of peripheral nerves. The iovera° treatment is powered by a patented miniaturization of traditional cryotherapy. The ioveraº system is 510k cleared in the U.S. for the blocking of pain, the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days and general surgical use. For more information, please visit http://www.iovera.com.

© 2018 Myoscience. All rights reserved. iovera° is a trademark of Myoscience. MKT-0521 REV A

Read the full story at https://www.prweb.com/releases/timothy_i_still_appointed_as_president_and_ceo_of_myoscience/prweb15802302.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris
2. Rett Syndrome Research Trust Names Timothy A. Riley Chief Scientific Officer and Chief Business Officer; Randall Carpenter Transitions to Chief Medical Officer
3. Nutritional quality at fast-food restaurants still needs improvement
4. Recovery of Hawaiian green sea turtles still short of historic levels, Stanford-led study suggests
5. ACS podcast: Many people still lack access to flush toilets, adequate sanitation
6. Seafood still considered a good source of nutrients but consumers confused on safety
7. Heavily logged forests still valuable for tropical wildlife
8. Bed bugs can survive freezing temperatures, but cold can still kill them
9. The science of baby-making still a mystery for many women
10. U of T report finds millions of Canadians still struggle to afford food
11. Still-fresh remnants of Exxon Valdez oil protected by boulders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2018)... ... 2018 , ... Our own cells may be the answer to eliminating chronic ... interventional spine and pain management specialist Jason Arora, DO, who says using a patient’s ... from a patient’s bone marrow are proving effective therapies for eliminating discogenic pain, namely ...
(Date:10/16/2018)... Utah and BOSTON (PRWEB) , ... ... ... CallTower , a global leader in delivering cloud-based enterprise-class unified communications and ... Boost delivers enhanced network stability by directly connecting CallTower data centers to ...
(Date:10/11/2018)... Pa. (PRWEB) , ... October 09, 2018 , ... ... a unique role in helping market-ready technologies expedite their path to health system ... vendors gain full EHR interoperability across all major EHR applications, enabling them to ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... ... October 02, 2018 , ... The Alliance for Clinical ... initiated validation of standards and testing of procedures for voluntary accreditation of clinical ... ACRES VP for Quality Management Systems and Chief Quality Officer, is underway in ...
(Date:9/28/2018)... ... September 28, 2018 , ... LabRoots , the ... scientists from around the world, is excited to announce Daniel Andrade, a 22-year-old ... the winner of the LabRoots Summer 2018 Textbook Scholarship, awarding him $1,000 to ...
(Date:9/27/2018)... ... 2018 , ... Medable was named DPharm Idol at this ... human digitome, a digital representation of human health and disease, by removing the ... data sources. Dr. Michelle Longmire, Co-Founder and CEO of Medable, explained that their ...
(Date:9/27/2018)... ... September 27, 2018 , ... Global ... announce today that Holotype HLA and other Omixon products will be featured among ... American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s ...
Breaking Biology Technology: